25 years of experience

Providing qPCR services since 2001

Multiple drug development programs

For pharmaceutical and biotech companies across Europe and the USA

Hundreds of publications

Including the MIQE guidelines and bioanalysis guidelines

Compliances

GLP-accredited, GCLP-compliant, and ISO/IEC 17025-compliant.

MOLECULAR CRO

Our global services

We are a leading CRO specializing in advanced molecular services, including PCR, NGS, and plasma proteomics, delivering customized, high-precision assays tailored for gene therapy, RNA therapeutics, and other advanced modalities.

Contact Details

TATAA Biocenter AB
Sofierogatan 3A:2
412 51 Gothenburg
SWEDEN

General Phone:
+46 (0)31 – 761 57 00

Email:
info@tataa.com

Services

Bioanalysis and biomarkers

Technologies

Molecular analysis methods

Two-tailed PCR technology

Short RNA quantification

The power of our approach

Strong collaboration, clear communication

Our scientists work as a team with yours, ensuring seamless collaboration and continuous progress because your success is our priority. With clear communication and dedicated support, you can feel confident and at ease, knowing your project is advancing.

Pioneering bioanalysis
for advanced therapies

TATAA Biocenter leads cell and gene therapy bioanalysis, shaping standards in a field with limited regulatory guidance. As MIQE co-authors and AAPS contributors (Hays et al., 2024), we define validation requirements with scientific rigor and regulatory foresight, driving confidence in therapeutic development.

Resources

Overview of bioanalysis in advanced therapies

  • Assay design and validation
  • Regulatory guidelines (EMA and FDA)
  • Challenges and best practices

Genomic biomarker analysis (DNA, RNA, miRNA, ctDNA etc,)

  • Technology overview
  • Analytical validation
  • Regulatory overview

Capability PDF

Download our latest brochure for a summary of our molecular CRO services and capabilities.